The ICMAB researcher
Judith Guasch has been appointed
Leader of a Max Planck Partner Group (Dynamic Biomimetics for Cancer Immunotherapy)
in collaboration with the
Max Planck Institute for Medical Research (Heidelberg, Germany). This position, started this same 2017, strengthens the collaboration of ICMAB with the
Max Planck Society through the research that Judith is performing, which is based on the development of biomimetic lymph nodes to help improving novel adoptive cell therapies, specially those designed to
treat cancer.